A detailed history of Veracity Capital LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Veracity Capital LLC holds 1,728 shares of CRL stock, worth $289,975. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,728
Previous 4,112 57.98%
Holding current value
$289,975
Previous $623,000 56.66%
% of portfolio
0.09%
Previous 0.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 07, 2025

SELL
$145.57 - $178.99 $347,038 - $426,712
-2,384 Reduced 57.98%
1,728 $270,000
Q2 2025

Jul 09, 2025

BUY
$99.75 - $151.89 $81,196 - $123,638
814 Added 24.68%
4,112 $623,000
Q1 2025

Apr 10, 2025

BUY
$150.52 - $190.14 $16,105 - $20,344
107 Added 3.35%
3,298 $496,000
Q4 2024

Jan 17, 2025

BUY
$178.58 - $220.69 $569,848 - $704,221
3,191 New
3,191 $589,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Veracity Capital LLC Portfolio

Follow Veracity Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veracity Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veracity Capital LLC with notifications on news.